Q96T66 AF NFT

Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidfme7kx4st2gtcmxzx6mlo3vzwcd3y5d7lymkooh7runlxkkmgte/metadata.json
IPFS of structure file: 
bafybeieoce3mr2h5ouoop57dapewdcnwkqwyd23g7kj4qq5rwf3eehqojy/AF-Q96T66-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x0D3f973941DB9ad80F3A1541fe23482e820dc1DD
First NFT owner address (bech32): 
genesis1p5leww2pmwddsre6z4qlug6g96pqmswa9kyt9e
Current NFT ID #266324 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
266324
Accession (UniProt):
Q96T66
Name::
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3
Experimental Method:
Predicted structure
Sequence source:
HOMO SAPIENS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q96T66 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q96T66|NMNA3_HUMAN Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 OS=Homo sapiens OX=9606 GN=NMNAT3 PE=1 SV=2 MKSRIPVVLLACGSFNPITNMHLRMFEVARDHLHQTGMYQVIQGIISPVNDTYGKKDLAASHHRVAMARLALQTSDWIRVDPWESEQAQWMETVKVLRHHHSKLLRSPPQMEGPDHGKALFSTPAAVPELKLLCGADVLKTFQTPNLWKDAHIQEIVEKFGLVCVGRVGHDPKGYIAESPILRMHQHNIHLAKEPVQNEISATYIRRALGQGQSVKYLIPDAVITYIKDHGLYTKGSTWKGKSTQSTEGKTS